Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2008-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/jc.2007-2734PMID 18413427PMCID PMC3214276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Laparoscopic adrenalectomy].

  2009cited by this paper
• Pasireotide (SOM230): development, mechanism of action and potential applications.

  2008cited by this paper
• [Medical treatment for Cushing's syndrome].

  2008cited by this paper
• Bilateral laparoscopic adrenalectomy for corticotrophin–dependent Cushing's syndrome: a review of the Mayo Clinic experience

  2008cited by this paper
• Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas.

  2008cited by this paper
• Etomidate Use for Cushing's Syndrome Caused by an Ectopic Adrenocorticotropic Hormone–Producing Tumor

  2007cited by this paper
• Ineffectiveness of rosiglitazone therapy in Nelson's syndrome.

  2007cited by this paper
• Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery.

  2007cited by this paper
• Dopamine agonists and the risk of cardiac-valve regurgitation.

  2007cited by this paper
• Improved Quality of Life After Bilateral Laparoscopic Adrenalectomy for Cushing's Disease: A 10-Year Experience

  2007cited by this paper
• Gamma Knife surgery for Cushing's disease.

  2007cited by this paper
• Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's Syndrome.

  2007cited by this paper
• Mifepristone (RU 486) in Cushing's syndrome.

  2007cited by this paper
• Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease.

  2007cited by this paper
• Valvular heart disease and the use of dopamine agonists for Parkinson's disease.

  2007cited by this paper
• Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances.

  2007cited by this paper
• Cushing's Syndrome: important issues in diagnosis and management.

  2006cited by this paper
• Early Morning Cortisol Levels as a Predictor of Remission After Transsphenoidal Surgery for Cushing’s Disease

  2006cited by this paper
• Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients.

  2006cited by this paper
• The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas.

  2006cited by this paper
• The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.

  2006cited by this paper
• Adrenal disorders in pregnancy.

  2006cited by this paper
• Effect of protracted treatment with rosiglitazone, a PPARγ agonist, in patients with Cushing's disease

  2006cited by this paper
• The diagnosis and differential diagnosis of endogenous Cushing's syndrome.

  2006cited by this paper
• Treatment of Cushing's disease: a retrospective clinical study of the latest 100 cases.

  2006cited by this paper
• Laparoscopic adrenalectomy.

  2006cited by this paper
• PPAR‐γ expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti‐proliferative effect of the glitazones is independent of the PPAR‐γ receptor

  2006cited by this paper
• The PPAR‐gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome

  2006cited by this paper
• Retinoic acid as a novel medical therapy for Cushing's disease in dogs.

  2006cited by this paper
• Surgical Treatment of Recurrent Cushing's Disease

  2006cited by this paper
• Cushing’s syndrome during pregnancy secondary to adrenal adenoma: Metyrapone treatment and laparoscopic adrenalectomy

  2006cited by this paper
• Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease.

  2006cited by this paper
• The Nelson's syndrome... revisited

  2005cited by this paper
• Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells.

  2005cited by this paper
• Long‐term remission rates after pituitary surgery for Cushing's disease: the need for long‐term surveillance

  2005cited by this paper
• Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.

  2005cited by this paper
• Novel Insights from Clinical Experience

  2005cited by this paper
• The Efficacy of Linear Accelerator Radiosurgery in the Management of Patients with Cushing’s Disease

  2005cited by this paper
• Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease.

  2005cited by this paper
• Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma.

  2005cited by this paper
• The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.

  2005cited by this paper
• Final adult height and body mass index after cure of paediatric Cushing's disease

  2005cited by this paper
• Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.

  2005cited by this paper
• Cabergoline plus lanreotide for ectopic Cushing's syndrome.

  2005cited by this paper
• The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment.

  2005cited by this paper
• Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.

  2005cited by this paper
• Cushing's syndrome during pregnancy: personal experience and review of the literature.

  2005cited by this paper
• Regulation of CRH-induced secretion of ACTH and corticosterone by SOM230 in rats.

  2005cited by this paper
• Pharmacologic management of Cushing syndrome : new targets for therapy.

  2005cited by this paper
• Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health.

  2005cited by this paper
• Pharmacologic Management of Cushing Syndrome

  2005cited by this paper
• Medical Management of Pituitary Adenomas: The Special Case of Management of the Pregnant Woman

  2004cited by this paper
• Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results.

  2004cited by this paper
• Medical Therapy of Cushing's Disease

  2004cited by this paper
• Dopamine receptor expression and function in corticotroph pituitary tumors.

  2004cited by this paper
• Successful treatment of childhood‐onset Cushing's disease is associated with persistent reduction in growth hormone secretion

  2004cited by this paper
• Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease.

  2003cited by this paper
• Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test.

  2003cited by this paper
• Diagnosis and complications of Cushing's syndrome: a consensus statement.

  2003influential reference
• PPAR-γ receptor ligands: novel therapy for pituitary adenomas

  2003cited by this paper
• PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

  2003cited by this paper
• Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.

  2003cited by this paper
• Long‐term follow‐up results of transsphenoidal surgery for Cushing’s disease in a single centre using strict criteria for remission

  2002cited by this paper
• Transsphenoidal Surgery for Cushing’s Disease: Endocrinological Follow-up Monitoring of 82 Patients

  2002cited by this paper
• Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas

  2002cited by this paper
• Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas.

  2002cited by this paper
• SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile.

  2002cited by this paper
• Undetectable postoperative cortisol does not always predict long‐term remission in Cushing’s disease: a single centre audit *

  2002cited by this paper
• Corticosteroids and Pregnancy

  2002cited by this paper
• [Cushing's disease and corticotrophic adenoma: results of pituitary microsurgery].

  2002cited by this paper
• Maladie de Cushing et adénome corticotrope: résultats de la microchirurgie hypophysaire

  2002cited by this paper
• Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome.

  2001cited by this paper
• Recurrent ACTH‐independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone

  2001cited by this paper
• Gushing syndrome doe to ectopic adrenocorticotropic hormone secretion

  2001cited by this paper
• Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?

  2001influential reference
• Cushing's syndrome.

  2001cited by this paper
• Retinoic acid prevents experimental Cushing syndrome.

  2001cited by this paper
• The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease.

  2001cited by this paper
• Cushing's syndrome.

  2001cited by this paper
• Effect of the Serotonin Antagonists Ritanserin and Ketanserin in Cushing's Disease

  2000cited by this paper
• Long-Term Mortality after Transsphenoidal Surgery for Cushing Disease

  1999cited by this paper
• Medical therapy for Cushing's disease.

  1999cited by this paper
• Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas.

  1998cited by this paper
• The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.

  1998cited by this paper
• Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid.

  1997cited by this paper
• The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.

  1997cited by this paper
• Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing's disease.

  1996cited by this paper
• Risk factors and long-term outcome in pituitary-dependent Cushing's disease.

  1996cited by this paper
• Somatostatin analogs in ectopic corticotropin production.

  1996cited by this paper
• Ketoconazole in the management of paraneoplastic Cushing's syndrome secondary to ectopic adrenocorticotropin production.

  1995cited by this paper
• Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group.

  1995cited by this paper
• Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.

  1994cited by this paper
• Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successfuI treatment

  1993cited by this paper
• The medical treatment of Cushing's syndrome.

  1993cited by this paper
• The relationship between cortisol production rate and serial serum Cortisol estimation in patients on medical therapy for Cushing's syndrome

  1993cited by this paper
• Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.

  1992cited by this paper
• Cushing's disease: a correlation of radiological, surgical and pathological findings with therapeutic results.

  1991cited by this paper
• Ketoconazole treatment in Cushing's syndrome: experience in 34 patients

  1991cited by this paper
• Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion

  1990cited by this paper
• LONG‐TERM FOLLOW‐UP OF LOW‐DOSE EXTERNAL PITUITARY IRRADIATION FOR CUSHING'S DISEASE

  1990cited by this paper

• Cavernous Sinus Medial Wall Resection: A Retrospective Single-Institution Study on Outcomes in Functional Pituitary Adenomas.

  2026cites this paper
• Postoperative adrenal crisis and atrial tachycardia associated with an ectopic ACTH-secreting thymic neuroendocrine tumor: a case report and literature review

  2026cites this paper
• Current and Future Central Nervous System Surgery-Part 2: Radiculopathy, Vertebral Fractures, and Intracranial Surgery.

  2026cites this paper
• Improved noninvasive diagnostic evaluations in treatment-naïve adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome

  2025cites this paper
• Surgical Treatment of Cushing's Disease: The Lessons Learned.

  2025cites this paper
• Clinical efficacy and safety of fluconazole treatment in patients with Cushing’s syndrome

  2025cites this paper
• Case Report: Ectopic CRH production by adrenal adenoma as a unique cause of the ACTH-dependent Cushing’s syndrome

  2025cites this paper
• Knowledge mapping of Cushing syndrome: A bibliometric analysis from 2000 to 2023

  2025cites this paper
• Cushing’s syndrome: Guidance on thromboprophylaxis at last

  2025cites this paper
• Etomidate in Severe Cushing Syndrome: A Systematic Review

  2025cites this paper
• Development and validation of clinical screening systems for Cushing disease in the United States

  2025cites this paper
• The USP8 Mutational Status in Combination With Postsurgical Cortisol Levels for Predicting Recurrence of Cushing Disease.

  2025cites this paper
• Predictors of Durable Remission After Successful Surgery for Cushing Disease: Results From the Multicenter RAPID Registry

  2024cites this paper
• Thyroid autoimmunity in different phenotypes of polycystic ovary syndrome: a single-center experience

  2024cites this paper
• Bone Morphogenetic Protein Signaling Agonist SB4 (BMPSB4) Inhibits Corticotroph Pituitary Neuroendocrine Tumors by Activation of Autophagy via a BMP4/SMADs-Dependent Pathway.

  2024cites this paper
• How to manage Cushing's disease after failed primary pituitary surgery.

  2024cites this paper
• Clinical guidelines of the Russian Medical Society on arterial Hypertension (RSH) and the Eurasian association of Cardiologists (EaC) for the diagnosis and treatment of arterial hypertension (2024)

  2024cites this paper
• Powder Self-Emulsifying Drug Delivery System for Mitotane: In Vitro and In Vivo Evaluation

  2024cites this paper
• Cushing syndrome in paediatric population: who and how to screen

  2024cites this paper
• Predicting delayed remission in Cushing’s disease using radiomics models: a multi-center study

  2024cites this paper
• Sleep disruption in patients with active and treated endogenous Cushing’s syndrome

  2024cites this paper
• A Case Report of an Elderly Patient With Cushing’s Disease and Multiple Chronic Conditions

  2024cites this paper
• Autoimmune Disorders Associated With Surgical Remission of Cushing’s Disease

  2024cites this paper
• Ectopic Adrenocorticotropic Hormone–Secreting Metastatic Pancreatic Neuroendocrine Tumor Initially Presenting as Gastrinoma: A Case Report

  2024cites this paper
• Structural basis for activation of somatostatin receptor 5 by cyclic neuropeptide agonists

  2024cites this paper
• Medium and Long-Term Data from a Series of 96 Endoscopic Transsphenoidal Surgeries for Cushing Disease

  2024cites this paper
• A Case Report of Bilateral Adrenal Gland Stereotactic Body Radiotherapy to Manage Hypercortisolemia in a Patient With Ectopic Adrenocorticotropic Hormone (ACTH) Production From a Metastatic Pancreatic Neuroendocrine Tumor

  2024cites this paper
• Clinical features and risk factors for postoperative recurrence in patients with Cushing's syndrome of different etiologies

  2024cites this paper
• Diagnosis and management of secondary adrenal crisis

  2024cites this paper
• Bilateral Inferior Petrosal Sinus Sampling Without Lateralization Is Less Accurate for the Diagnosis of Cushing Disease.

  2024cites this paper
• The Impact of Surgical Telementoring on Reducing the Complication Rate in Endoscopic Endonasal Surgery of the Skull Base

  2024cites this paper
• Clinico-radiological parameters, biochemical and molecular alterations predicting remission and recurrence after surgical treatment of corticotroph adenomas - Cushing's disease.

  2024cites this paper
• Retrospective analysis of the outcomes of endoscopic transsphenoidal surgery for Cushing’s disease

  2024cites this paper
• A transmandibular lateral transsphenoidal navigated surgical approach to access a pituitary macroadenoma in a warmblood mare

  2024cites this paper
• Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases

  2024influential citation
• An Integrated Clinical Score to Predict Remission in Cushing’s Disease

  2023cites this paper
• Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology

  2023cites this paper
• Adenomi ipofisari o tumori neuroendocrini ipofisari: attualità e consenso

  2023cites this paper
• Interpetrosal sphingosine-1-phosphate ratio predicting Cushing’s disease tumor laterality and remission after surgery

  2023cites this paper
• Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease.

  2023cites this paper
• Myopathies of endocrine origin: A review for physicians.

  2023cites this paper
• An individualized approach to the management of Cushing disease

  2023cites this paper
• Effect of intercavernous sinus drainage pattern on exactness of bilateral inferior petrosal sinus sampling results in foretell the area of Cushing’s disease tumors

  2023cites this paper
• Challenges in post-operative management of Cushing disease

  2023cites this paper
• Post-Operative Serum Cortisol and Cushing Disease Recurrence in Patients with Corticotroph Adenomas.

  2023cites this paper
• Neurosurgical aspects and clinical outcomes on the treatment of Cushing disease in pediatric patients: Case series and literature review

  2023cites this paper
• Adrenocortical carcinoma in a 10-month-old infant: A literature review and a rare case report

  2023cites this paper
• Cortisol: Analytical and clinical determinants.

  2023cites this paper
• Case Report: Opposite Tumoral and Hormonal Responses to Low-dose Pasireotide in Cushing's Disease.

  2023cites this paper
• ACTH‐secreting pancreatic neuroendocrine neoplasms: A case‐series

  2023cites this paper
• Two- and three-dimensional endoscopic endonasal surgery of large and giant pituitary adenomas—outcome analysis of a series of 62 patients from a single pituitary center

  2023cites this paper
• An evaluation of pharmacological options for Cushing’s disease: what are the state-of-the-art options?

  2023cites this paper
• Adénomes hypophysaires ou tumeurs neuroendocrines hypophysaires : actualités et consensus

  2023cites this paper
• Advances in Molecular Pathophysiology and Targeted Therapy for Cushing’s Disease

  2023cites this paper
• Recurrent Cushing's disease: An extensive review on pros and cons of different therapeutic approaches.

  2023cites this paper
• Gamma Knife Radiosurgery for Cushing’s Disease: Evaluation of Biological Effective Dose from a Single-Center Experience

  2023cites this paper
• Site-specific performance of 68Ga-DOTATATE PET/CT in detecting tumors with ectopic adrenocorticotropic hormone secretion

  2023cites this paper
• Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies

  2023cites this paper
• Adrenal insufficiency (hypocorticism) on the background of adrenalectomy for corticosteroma

  2023cites this paper
• Bone mineral density in patients with Cushing’s syndrome

  2023cites this paper
• The recovery time of hypothalamic-pituitary-adrenal axis after curative surgery in Cushing’s disease and its related factor

  2023cites this paper
• Risk of impulse control disorders in patients with Cushing’s disease: do not blame cabergoline but do not give up caution

  2023cites this paper
• Cushing disease in pediatrics: an update

  2023cites this paper
• Nasal and Sellar Anatomic Variations in Pituitary-Dependent Cushing Disease

  2023cites this paper
• Effect of pituitary‐dependent hypercortisolism on the survival of dogs treated with radiotherapy for pituitary macroadenomas

  2023cites this paper
• Paraneoplastisch syndroom van Cushing

  2022cites this paper
• Responsiveness to DDAVP in Cushing’s disease is associated with USP8 mutations through enhancing AVPR1B promoter activity

  2022cites this paper
• Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome

  2022cites this paper
• The Mount Sinai Clinical Pathway for the Diagnosis and Management of Hypercortisolism due to Ectopic ACTH Syndrome

  2022cites this paper
• Role of radiosurgery in the treatment of Cushing's disease

  2022cites this paper
• Osilodrostat oral tablets for adults with Cushing’s disease

  2022cites this paper
• Integrative clinical, radiological and molecular analysis for predicting remission and recurrence of Cushing's disease.

  2022cites this paper
• The value of intraoperative MRI for resection of functional pituitary adenomas—a critical assessment of a consecutive single-center series of 114 cases

  2022cites this paper
• Randomized Trial of Osilodrostat for the Treatment of Cushing Disease

  2022cites this paper
• Pharmacological management of severe Cushing’s syndrome: the role of etomidate

  2022cites this paper
• Perioperative Management of a Patient With Cushing Disease

  2022cites this paper
• Surgical Management of Hypercortisolism from ACTH-Secreting Pituitary Adenomas

  2022cites this paper
• 8 Natural History and Management Options for Cushing’s Disease Cushing’s disease

  2022cites this paper
• Cushing’s Disease

  2022cites this paper
• A Comprehensive Approach to Predicting the Outcomes of Transsphenoidal Endoscopic Adenomectomy in Patients with Cushing’s Disease

  2022cites this paper
• The recovery time of hypothalamic-pituitary-adrenal axis after curative surgery in Cushing’s disease and its predictor

  2022cites this paper
• Intraoperative Predictor of Remission in Cushing Disease

  2022cites this paper
• Presurgical predictive factors of surgical remission in Cushing's disease. Study of 32 cases.

  2022cites this paper
• Recurrent Neuroendocrine Tumor of the Cervix Presenting With Ectopic Cushing’s Syndrome

  2022cites this paper
• Mifepristone Treatment of Impaired Consciousness Caused by Cushing Syndrome

  2022cites this paper
• Individualized medical treatment options in Cushing disease

  2022cites this paper
• Levoketoconazole treatment in endogenous Cushing’s syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes

  2022cites this paper
• Surgery as a first-line option for prolactinomas

  2022cites this paper
• Pituitary tumor centers of excellence for Cushing’s disease

  2022cites this paper
• Osilodrostat in Cushing’s disease: the management of its efficacy and the pitfalls of post-surgical results

  2022cites this paper
• Diagnosis and Management of Cushing's Disease: A Survey of Endocrinologists from the Middle East and North Africa

  2022cites this paper
• Patient on Multiple Hormone Replacement Therapy for Hip Arthroplasty: How to Omit Noise and Be Focused?

  2022cites this paper
• Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation

  2022cites this paper
• Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-Dependent Cushing Syndrome Patients.

  2022cites this paper
• Ectopic ACTH syndrome complicated by hypercortisolism-associated urolithiasis. A case report

  2022cites this paper
• Disorders of the adrenal cortex: Genetic and molecular aspects

  2022cites this paper
• Exploration biochimique de la corticosurrénale

  2022cites this paper
• Pediatric Cushing's disease: Case reports and retrospective review.

  2022cites this paper
• Presurgical predictive factors of surgical remission in Cushing's disease. Study of 32 cases.

  2021cites this paper
• Pasireotide treatment in Cushing’s disease: A single tertiary center’s experience

  2021cites this paper